PACB
Pacific Biosciences of California
2.90$
+13.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.8% | -33.5% | -7.2% | +11.0% | -1.9% | -5.3% | +7.0% | -3.3% | +16.1% | -16.7% | +4.9% | – | |
| – | +29.1% | -43.6% | +9.3% | -0.4% | -2.7% | +32.1% | -34.9% | -6.8% | +19.4% | -12.8% | +8.3% | – | |
| – | -46.5% | +17.9% | -47.4% | +68.5% | +0.5% | -113.6% | – | +2.6% | +11.2% | -23.3% | -1.6% | – | |
| – | -6.3% | -2.4% | -11.4% | -33.7% | +7.6% | +5.8% | -22.5% | +1.4% | +0.1% | -14.3% | +17.4% | – | |
| – | +5.9% | -4.9% | +4.9% | -4.6% | -4.8% | -3.5% | -9.9% | -14.0% | +9.5% | -8.5% | +7.2% | – | |
| – | -3.3% | -4.6% | +96.2% | -59.2% | +120.1% | +162.2% | -86.1% | -9.5% | +7.5% | -12.4% | +12.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.5% | +0.1% | -0.9% | -0.1% | -22.1% | -37.0% | +0.1% | +0.1% | +0.1% | +0.0% | +21.3% | – | |
| – | – | – | – | – | – | -15,968.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -195.6% | – | +994.3% | -47.3% | -8.9% | -68.5% | – | |
| – | – | – | – | – | – | -18,070.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -416.4% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.